Financial giants have made a conspicuous bearish move on Illumina. Our analysis of options history for Illumina ILMN revealed 23 unusual trades.
Delving into the details, we found 21% of traders were bullish, while 78% showed bearish tendencies. Out of all the trades we spotted, 15 were puts, with a value of $2,573,760, and 8 were calls, valued at $730,080.
Predicted Price Range
After evaluating the trading volumes and Open Interest, it's evident that the major market movers are focusing on a price band between $95.0 and $200.0 for Illumina, spanning the last three months.
Analyzing Volume & Open Interest
Looking at the volume and open interest is an insightful way to conduct due diligence on a stock.
This data can help you track the liquidity and interest for Illumina's options for a given strike price.
Below, we can observe the evolution of the volume and open interest of calls and puts, respectively, for all of Illumina's whale activity within a strike price range from $95.0 to $200.0 in the last 30 days.
Illumina Option Activity Analysis: Last 30 Days
Biggest Options Spotted:
| Symbol | PUT/CALL | Trade Type | Sentiment | Exp. Date | Strike Price | Total Trade Price | Open Interest | Volume |
|---|---|---|---|---|---|---|---|---|
| ILMN | PUT | TRADE | BEARISH | 01/17/25 | $200.00 | $509.9K | 486 | 406 |
| ILMN | PUT | TRADE | BEARISH | 01/17/25 | $200.00 | $490.3K | 486 | 155 |
| ILMN | PUT | SWEEP | NEUTRAL | 02/16/24 | $95.00 | $329.0K | 39 | 0 |
| ILMN | CALL | SWEEP | BULLISH | 01/19/24 | $132.00 | $251.0K | 5 | 21 |
| ILMN | PUT | TRADE | BULLISH | 01/17/25 | $200.00 | $240.9K | 486 | 128 |
About Illumina
Illumina provides tools and services to analyze genetic material with life science and clinical lab applications. The company generates about 90% of its revenue from sequencing instruments, consumables, and services. Illumina's high-throughput technology enables whole genome sequencing in humans and other large organisms. Its lower throughput tools enable applications that require smaller data outputs, such as viral and cancer tumor screening. Illumina also sells microarrays (about 10% of sales) that enable lower-cost, focused genetic screening with primarily consumer and agricultural applications.
Following our analysis of the options activities associated with Illumina, we pivot to a closer look at the company's own performance.
Where Is Illumina Standing Right Now?
- Trading volume stands at 1,231,665, with ILMN's price down by -1.36%, positioned at $135.74.
- RSI indicators show the stock to be may be approaching overbought.
- Earnings announcement expected in 34 days.
Options trading presents higher risks and potential rewards. Astute traders manage these risks by continually educating themselves, adapting their strategies, monitoring multiple indicators, and keeping a close eye on market movements. Stay informed about the latest Illumina options trades with real-time alerts from Benzinga Pro.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Date of Trade | ticker | Put/Call | Strike Price | DTE | Sentiment |
|---|
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
